Also trades as: CHIZF (OTC) · $vol 0M

HK$1.19 ($0.15)

-0.04 (-3.66%)

Weekly Expected Move ±4.9%

HK$1 HK$1 HK$1 HK$1 HK$1

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 35 · HK$6.2B mcap · 3.35B float · 0.359% daily turnover

Revenue

$14.4B -13.0% ▼

5Y CAGR: -0.6%

Gross Profit

$6.9B -12.1% ▼

5Y CAGR: -5.4%

Operating Income

$298M -11.3% ▼

5Y CAGR: -34.6%

Net Income

-$333M -716.3% ▼

EPS (Diluted)

$-0.07 -718.7% ▼

EBITDA

$1.4B -23.3% ▼

5Y CAGR: -15.0%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$19.1B	$14.3B	$18.1B	$16.5B	$14.4B
YoY Growth	+28.7%	-24.9%	+26.7%	-8.9%	-13.0%
Cost of Revenue	$7.2B	$7.1B	$8.8B	$8.7B	$7.5B
Gross Profit	$11.8B	$7.2B	$9.3B	$7.9B	$6.9B
Gross Margin	62.1%	50.3%	51.2%	47.6%	48.1%
R&D Expenses	$694M	$612M	$686M	$596M	$498M
SG&A Expenses	$8.6B	$5.5B	$7.4B	$6.5B	$6.1B
Operating Expenses	$9.1B	$6.1B	$7.8B	$7.5B	$6.6B
Operating Income	$2.8B	$1.1B	$1.4B	$336M	$298M
Operating Margin	14.4%	7.4%	7.9%	2.0%	2.1%
Interest Expense	$222M	$221M	$199M	$236M	$97M
Income Before Tax	$2.5B	$840M	$1.2B	$163M	-$359M
Tax Expense	$397M	$119M	-$172M	$142M	$88M
Net Income	$1.9B	$764M	$1.3B	$54M	-$333M
Net Margin	10.1%	5.3%	7.1%	0.3%	-2.3%
EPS (Diluted)	$0.38	$0.15	$0.26	$0.01	$-0.07
EBITDA	$3.6B	$2.2B	$2.6B	$1.8B	$1.4B
Shares Outstanding	5.04B	5.04B	5.04B	5.04B	5.04B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$8.4B	$9.3B	$8.8B	$8.4B	$8.1B	$7.5B	$7.3B	$5.4B
Cost of Revenue	$4.1B	$4.5B	$4.3B	$4.3B	$4.3B	$3.8B	$3.8B	$2.8B
Gross Profit	$4.2B	$4.8B	$4.5B	$4.1B	$3.8B	$3.6B	$3.5B	$2.5B
Gross Margin	50.6%	51.1%	51.2%	48.4%	46.7%	48.7%	47.5%	47.5%
R&D Expenses	$294M	$314M	$372M	$268M	$328M	$256M	$255M	$185M
SG&A Expenses	$3.4B	$3.7B	$3.8B	$3.3B	$3.2B	$3.2B	$3.0B	$2.5B
Operating Expenses	$3.8B	$4.0B	$3.9B	$3.7B	$3.8B	$3.7B	$3.7B	$2.7B
Operating Income	$494M	$814M	$613M	$385M	-$49M	-$36M	-$233M	-$181M
Operating Margin	5.9%	8.8%	7.0%	4.6%	-0.6%	-0.5%	-3.2%	-3.4%
Interest Expense	$274M	$238M	-$39M	$0	$56M	$27M	$51M	$33M
Income Before Tax	$370M	$707M	$518M	$299M	-$136M	-$83M	-$285M	-$749M
Tax Expense	$71M	$90M	-$261M	$85M	$57M	$59M	$31M	$74M
Net Income	$351M	$579M	$706M	$211M	-$157M	-$108M	-$234M	-$766M
Net Margin	4.2%	6.2%	8.0%	2.5%	-1.9%	-1.4%	-3.2%	-14.3%
EPS (Diluted)	$0.07	$0.12	$0.14	$0.04	$-0.03	$-0.02	$-0.05	$-0.16
EBITDA	$1.2B	$1.3B	$1.1B	$908M	$917M	$721M	$697M	$378M
Shares Outstanding	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B	5.04B

0570.HK HKSE